We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Calls for ‘Clear, Concise’ Abuse and Dependence Labeling
FDA Calls for ‘Clear, Concise’ Abuse and Dependence Labeling
The FDA flagged the importance of abuse and dependence labeling for prescription drugs and biologics in a new draft guidance issued Monday — calling them key factors in the agency’s drug reviews.